Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Trientine Treatment for Wilson's Disease”

5 trials

Showing 5 of 5 results

Large-scale testing (Phase 3)Looking for participantsNCT07465718
What this trial is testing

Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.

Who this might be right for
Wilson's Disease
Orphalan 38
Not applicableStudy completedNCT03299829
What this trial is testing

A Retrospective Study to Assess the Clinical Efficacy and Safety of Trientine in Wilson's Disease Patients

Who this might be right for
Trientine Treatment for Wilson's Disease
Excelsior 48
Not applicableStudy completedNCT01472874
What this trial is testing

Single Daily Dosage of Trientine for Maintenance Treatment for Wilson Disease

Who this might be right for
Wilson Disease
Yale University 8
Large-scale testing (Phase 3)Study completedNCT03539952
What this trial is testing

Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease

Who this might be right for
Wilson Disease
Orphalan 77
Early research (Phase 1)Study completedNCT01874028
What this trial is testing

Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients

Who this might be right for
Wilson's Disease
Univar BV 20

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation